DK1112065T3 - Farmaceutisk præparat omfattende entacapon eller nitecapon foruden et krydsbundet cellulosederivat - Google Patents

Farmaceutisk præparat omfattende entacapon eller nitecapon foruden et krydsbundet cellulosederivat

Info

Publication number
DK1112065T3
DK1112065T3 DK99944655T DK99944655T DK1112065T3 DK 1112065 T3 DK1112065 T3 DK 1112065T3 DK 99944655 T DK99944655 T DK 99944655T DK 99944655 T DK99944655 T DK 99944655T DK 1112065 T3 DK1112065 T3 DK 1112065T3
Authority
DK
Denmark
Prior art keywords
nitecapone
entacapone
cross
addition
pharmaceutical composition
Prior art date
Application number
DK99944655T
Other languages
Danish (da)
English (en)
Inventor
Kari Vahervuo
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22542186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1112065(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of DK1112065T3 publication Critical patent/DK1112065T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DK99944655T 1998-09-14 1999-09-13 Farmaceutisk præparat omfattende entacapon eller nitecapon foruden et krydsbundet cellulosederivat DK1112065T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,263 US6599530B2 (en) 1998-09-14 1998-09-14 Oral compacted composition comprising catechol derivatives
PCT/FI1999/000740 WO2000015196A1 (en) 1998-09-14 1999-09-13 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Publications (1)

Publication Number Publication Date
DK1112065T3 true DK1112065T3 (da) 2004-04-05

Family

ID=22542186

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99944655T DK1112065T3 (da) 1998-09-14 1999-09-13 Farmaceutisk præparat omfattende entacapon eller nitecapon foruden et krydsbundet cellulosederivat

Country Status (39)

Country Link
US (1) US6599530B2 (pt)
EP (1) EP1112065B1 (pt)
JP (1) JP4619537B2 (pt)
KR (1) KR100732187B1 (pt)
CN (1) CN1151778C (pt)
AR (1) AR021806A1 (pt)
AT (1) ATE256454T1 (pt)
AU (1) AU746889B2 (pt)
BG (1) BG65041B1 (pt)
BR (1) BR9913681A (pt)
CA (1) CA2342634C (pt)
CO (1) CO5130008A1 (pt)
CZ (1) CZ293960B6 (pt)
DE (1) DE69913714T2 (pt)
DK (1) DK1112065T3 (pt)
EA (1) EA003282B1 (pt)
EE (1) EE04657B1 (pt)
ES (1) ES2213381T3 (pt)
GE (1) GEP20033062B (pt)
HK (1) HK1039750B (pt)
HR (1) HRP20010277B1 (pt)
HU (1) HU228910B1 (pt)
ID (1) ID29026A (pt)
IL (1) IL141681A0 (pt)
ME (1) ME00706B (pt)
MY (1) MY124394A (pt)
NO (1) NO331641B1 (pt)
NZ (1) NZ510583A (pt)
PE (1) PE20001060A1 (pt)
PL (1) PL193454B1 (pt)
PT (1) PT1112065E (pt)
RS (1) RS49723B (pt)
SI (1) SI1112065T1 (pt)
SK (1) SK284049B6 (pt)
TR (1) TR200100752T2 (pt)
TW (1) TWI222367B (pt)
UA (1) UA73925C2 (pt)
WO (1) WO2000015196A1 (pt)
ZA (1) ZA200102084B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109453B (fi) 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
FI20000635A0 (fi) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US20060173074A1 (en) 2004-11-10 2006-08-03 Juha Ellmen Treatment of restless legs syndrome
AU2012216377C1 (en) * 2005-06-08 2013-10-10 Orion Corporation Oral dosage form
PL1896006T3 (pl) * 2005-06-08 2010-03-31 Orion Corp Sposób wytwarzania granulek zawierających entakapon do postaci dawkowania doustnego
WO2007069274A2 (en) * 2005-11-09 2007-06-21 Torrent Pharmaceuticals Limited Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
EP1991241A4 (en) * 2006-02-23 2009-07-08 Iomedix Sleep Internat Srl COMPOSITIONS AND METHODS FOR INTRODUCING AND MAINTAINING HIGH-QUALITY SLEEPING
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent
WO2007113371A1 (en) * 2006-03-31 2007-10-11 Iprbox Oy Pharmaceutical composition and preparation method thereof
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
EP2252284B1 (en) * 2008-02-06 2011-05-25 Wockhardt Research Centre Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
MX2010008707A (es) * 2008-02-06 2011-03-25 Wockhardt Ltd Composiciones farmaceuticas de entacapona comicronizada con alcoholes de azucar.
CA2734972C (en) * 2008-08-22 2017-03-28 Wockhardt Research Centre An extended release pharmaceutical composition of entacapone or salts thereof
US9750702B2 (en) * 2009-12-25 2017-09-05 Innopharmax, Inc. Pharmaceutical composition for treating parkinson's disease and preparation method thereof
WO2012147099A1 (en) 2011-04-25 2012-11-01 Suven Nishtaa Pharma Pvt. Ltd. Pharmaceutical compositions of levodopa, carbidopa and entacapone
CA2833443C (en) * 2011-04-26 2017-11-07 Innopharmax, Inc. A composition of entacapone
RU2017120184A (ru) 2014-11-28 2018-12-28 БИАЛ - ПОРТЕЛА ЭНД Ка, С.А. Лекарства для замедления течения болезни паркинсона
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3275433A1 (en) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Sustained release composition comprising micronized tolcapone
CN106236720A (zh) * 2016-08-29 2016-12-21 海南通用康力制药有限公司 一种恩他卡朋的药物组合物及其制备方法
CN113274362A (zh) * 2021-03-31 2021-08-20 海南通用康力制药有限公司 恩他卡朋片的生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880701098A (ko) * 1986-04-01 1988-07-25 로버어트 에이 아미테이지 메틸프레드니솔론/소디움 카르복시메틸 전분 정제 조성물
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet

Also Published As

Publication number Publication date
HK1039750A1 (en) 2002-05-10
KR100732187B1 (ko) 2007-06-27
HRP20010277A2 (en) 2002-06-30
TR200100752T2 (tr) 2001-10-22
ATE256454T1 (de) 2004-01-15
HRP20010277B1 (hr) 2010-10-31
HUP0103454A2 (hu) 2002-01-28
JP2002524493A (ja) 2002-08-06
CO5130008A1 (es) 2002-02-27
NO20011278L (no) 2001-03-13
PL346618A1 (en) 2002-02-25
SK3072001A3 (en) 2002-05-09
HK1039750B (zh) 2005-02-18
ZA200102084B (en) 2002-06-13
EE04657B1 (et) 2006-08-15
UA73925C2 (uk) 2005-10-17
DE69913714D1 (de) 2004-01-29
CA2342634A1 (en) 2000-03-23
EP1112065B1 (en) 2003-12-17
NO331641B1 (no) 2012-02-13
EP1112065A1 (en) 2001-07-04
PL193454B1 (pl) 2007-02-28
BR9913681A (pt) 2001-06-05
PE20001060A1 (es) 2000-10-20
AU5748299A (en) 2000-04-03
CA2342634C (en) 2008-01-29
AR021806A1 (es) 2002-08-07
PT1112065E (pt) 2004-04-30
ES2213381T3 (es) 2004-08-16
AU746889B2 (en) 2002-05-02
BG105436A (en) 2001-11-30
IL141681A0 (en) 2002-03-10
KR20010075084A (ko) 2001-08-09
EA200100354A1 (ru) 2001-08-27
EE200100147A (et) 2002-06-17
BG65041B1 (bg) 2007-01-31
YU19301A (sh) 2003-02-28
ID29026A (id) 2001-07-26
JP4619537B2 (ja) 2011-01-26
SI1112065T1 (en) 2004-04-30
US6599530B2 (en) 2003-07-29
SK284049B6 (sk) 2004-08-03
EA003282B1 (ru) 2003-04-24
RS49723B (sr) 2007-12-31
ME00706B (me) 2007-12-31
CN1151778C (zh) 2004-06-02
NO20011278D0 (no) 2001-03-13
NZ510583A (en) 2002-09-27
HUP0103454A3 (en) 2003-11-28
GEP20033062B (en) 2003-09-25
TWI222367B (en) 2004-10-21
DE69913714T2 (de) 2004-10-07
WO2000015196A1 (en) 2000-03-23
HU228910B1 (en) 2013-06-28
CZ2001792A3 (cs) 2001-08-15
US20020132009A1 (en) 2002-09-19
MY124394A (en) 2006-06-30
CN1319005A (zh) 2001-10-24
CZ293960B6 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
DK1112065T3 (da) Farmaceutisk præparat omfattende entacapon eller nitecapon foruden et krydsbundet cellulosederivat
DE122007000035I1 (de) 5-Alkyl-2-Arylaminophenylessigs{ure und derivative
NO20010078L (no) Fenoksyeddiksyrederivat og farmasøytisk sammensetning omfattende det samme
PT996418E (pt) Composicoes dermatologicas
IS2076B (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
ID29262A (id) Komposisi farmasi
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
ID22053A (id) Turunan asam aminofosfonat dalam sediaan farmasi
ID27201A (id) Komposisi farmasi
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
NO20010089D0 (no) Farmasöytisk levotyroksinpreparat
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
BRPI9703099B8 (pt) derivado de carboidrato, e, composição farmacêutica
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
NO993067L (no) Farmasoeytiske sammensetninger for frysetoerking
ID29294A (id) Komposisi farmasi
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
DE69736678D1 (de) Dermatologische zusammensetzungen
ID26215A (id) Komposisi farmasi
ITMI962628A0 (it) Composizione farmaceutica
DK1194186T3 (da) Cardioaktiv sammensætning omfattende L-carnitin og derivater heraf samt i crataegus/i ekstrakter
DE69503368D1 (de) Dermatologisches präparat
FI974610A0 (fi) Farmaceutiskt preparat i gelform
ID23531A (id) Komposisi farmasi